HPBCD against acute and subacute infarcts in a mouse model of ischemic stroke
HPβCD has also been investigated as an active pharmaceutical ingredient (API) for the prospective treatment of ischemic stroke. We previously
A forum for researchers, students and applicants in the field of cyclodextrin technology
HPβCD has also been investigated as an active pharmaceutical ingredient (API) for the prospective treatment of ischemic stroke. We previously
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona
This post was written by Ibrahim Hussein. Cyclodextrin-based carriers have evolved beyond their traditional role as solubilizing agents toward ligand-targeted,
The central nervous system ( CNS) is increasingly recognized as a cholesterol-rich organ. While the brain accounts for approximately 5%
Nanoemulsions, which are characterized by their nanometer-scale droplets, have gained significant attention in different fields, such as medicine, food, cosmetics,
Addressing disorders related to the central nervous system (CNS) remains a complex challenge because of the presence of the blood-brain
Huntington’s disease (HD) is a progressive inherited neurodegenerative disease caused by a CAG repeat expansion in the huntingtin gene, which
With immense sadness we have to announce that an outstanding Scientist, Dr. David Begley passed away on Thursday 6th July
The complexity and organization of the central nervous system (CNS) is widely modulated by the presence of the blood–brain barrier
“4th Edition of Global Conference on Pharmaceutics and Drug Delivery Systems” (PDDS 2021) is going to be held during September